Ucb

Developer of therapies for immunological and neurological disorders

placeBrussels, Brussels, Belgium calendar_todayFounded 1928 groups79 employees language ucb.com

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
Belgium28.3%
United States20.5%
United Kingdom10.4%
Germany7.2%
France6.1%

Investor mix

6 investors on record.

Investor typeCountShare
Private equity233%
Accelerator & incubator117%
Other / undisclosed350%

Share of voice

Share of voice in Belgium: 100% of web traffic across its competitive set; worldwide: 19.5%.

Coming soon